title: The IFN-1 > BID > ROS pathway: Linking DNA damage with HSPC malfunction.
authors.affiliation: a Department of Biological Regulation , Weizman Institute of Science , Rehovot , Israel.
authors.forename: Atan
authors.initials: A
authors.lastname: Gross
authors.affiliation: b Institute of Immunology , University Hospital , Ulm , Germany.|c Department of Pediatrics and Children's Research Institute , University of Texas Southwestern Medical Center , Dallas , TX , USA.
authors.forename: Alpaslan
authors.initials: A
authors.lastname: Tasdogan
authors.affiliation: b Institute of Immunology , University Hospital , Ulm , Germany.
authors.forename: Hans Joerg
authors.initials: HJ
authors.lastname: Fehling
mesh_terms: D000818:Animals; D051023:BH3 Interacting Domain Death Agonist Protein / Q000378:metabolism*; D004249:DNA Damage; D006412:Hematopoietic Stem Cells / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D007370:Interferon Type I / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D051023:BH3 Interacting Domain Death Agonist Protein; D007370:Interferon Type I; D017382:Reactive Oxygen Species
keywords: ATM; BID; DNA damage; HSPC malfunction; MLL5; MTCH2; ROS; interferon; mitochondria